World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3543)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

441

HTML

2920

Figures (1-2)

182

Sum=3543

May 7, 2011 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Williet N, Dubreuil O, Boussaha T, Trouilloud I, Landi B, Housset M, Botti M, Rougier P, Belghiti J, Taieb J. Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma. World J Gastroenterol 2011; 17(17): 2255-2258 [PMID: 21633538 DOI: 10.3748/wjg.v17.i17.2255]
URL:	https://www.wjgnet.com/1007-9327/full/v17/i17/2255.htm

Number	Citing Articles
1	Parissa Tabrizian, Rebecca Marino, Pierce K.H. Chow. Liver resection and transplantation in the era of checkpoint inhibitors. JHEP Reports 2024; 6(11): 101181 doi: 10.1016/j.jhepr.2024.101181
2	Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550 Abstract(524) \| Core Tip(510) \| Full Article(HTML)(3238) \| Full Article (PDF)-1463K(414) \| Full Article (Word)-1068K(127) \| Audio-872K(22) \| Peer-Review Report-175K(166) \| Answering Reviewers-64K(110) \| Times Cited (10) \| Total Visits (7955) \| Open
3	Joseph W. Franses, Andrew X. Zhu. Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present. Clinical Cancer Research 2022; 28(13): 2738 doi: 10.1158/1078-0432.CCR-22-0025
4	Zhengfeng Yin. Hepatocellular Carcinoma. 2016; : 167 doi: 10.1007/978-3-319-34214-6_12
5	Huapeng Lin, Xiaocheng Li, Ye Liu, Yingchun Hu. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma. ANZ Journal of Surgery 2018; 88(10) doi: 10.1111/ans.14387
6	Junichi Arita, Akihiko Ichida, Rihito Nagata, Yuichiro Mihara, Yoshikuni Kawaguchi, Takeaki Ishizawa, Nobuhisa Akamatsu, Junichi Kaneko, Kiyoshi Hasegawa. Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(7): 732 doi: 10.1002/jhbp.1135
7	Thomas U Marron, Myron Schwartz, Virginia Corbett, Miriam Merad. Neoadjuvant Immunotherapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 571 doi: 10.2147/JHC.S340935
8	Gemcitabine/oxaliplatin/sorafenib. Reactions Weekly 2021; 1853(1): 216 doi: 10.1007/s40278-021-95082-2
9	Shinya Imada, Kohei Ishiyama, Kentaro Ide, Tsuyoshi Kobayashi, Hironobu Amano, Hirotaka Tashiro, Koji Arihiro, Hiroshi Aikata, Kazuaki Chayama, Hideki Ohdan. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma. World Journal of Surgical Oncology 2013; 11(1) doi: 10.1186/1477-7819-11-177
10	Xin-Lei Gong, Shu-Kui Qin. Progress in systemic therapy of advanced hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(29): 6582-6594 doi: 10.3748/wjg.v22.i29.6582 Abstract(1187) \| Core Tip(1025) \| Full Article(HTML)(5885) \| Full Article (PDF)-1038K(932) \| Full Article (Word)-233K(272) \| Audio-579K(23) \| Peer-Review Report-117K(185) \| Answering Reviewers-146K(202) \| Times Cited (35) \| Total Visits (13839) \| Open
11	Louise Barbier, David Fuks, Patrick Pessaux, Fabrice Muscari, Yves-Patrice Le Treut, Sandrine Faivre, Jacques Belghiti. Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study. Annals of Surgical Oncology 2013; 20(11): 3603 doi: 10.1245/s10434-013-3029-z
12	Junichi Shindoh, Yusuke Kawamura, Yuta Kobayashi, Masahiro Kobayashi, Norio Akuta, Satoshi Okubo, Yoshiyuki Suzuki, Masaji Hashimoto. Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(12): 7663 doi: 10.1245/s10434-021-09974-0
13	Seiji Oguro, Satoshi Nara, Shunsuke Kondo, Shutaro Hori, Yoji Kishi, Minoru Esaki, Kazuaki Shimada, Tomoo Kosuge, Takuji Okusaka, Hidenori Ojima. A Case of Pathological Complete Response after Combination Chemotherapy by Sorafenib and Cisplatin Hepatic Arterial Infusion for an Advanced Hepatocellular Carcinoma. The Japanese Journal of Gastroenterological Surgery 2013; 46(12): 915 doi: 10.5833/jjgs.2013.0044
14	Vera Himmelsbach, Christine Koch, Jörg Trojan, Fabian Finkelmeier. Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?. Journal of Hepatocellular Carcinoma 2024; : 363 doi: 10.2147/JHC.S443218
15	Alexa Childs, Gloryanne Aidoo-Micah, Mala K. Maini, Tim Meyer. Immunotherapy for hepatocellular carcinoma. JHEP Reports 2024; 6(10): 101130 doi: 10.1016/j.jhepr.2024.101130